Strides to pay dividend of Rs 500 per share post Agila saleArcolab said it will pay a special dividend of Rs 500 per equity share following the completion of its sale of Agila Specialties division t...
10 Dec, 2013, 02.48 PM IST
Agila, with first class people, is a very high-quality asset: Rajiv MalikMylan has completed the acquisition of Agila Specialties division from Strides Arcolab for a total value of $1.75 billion (about Rs10,800 c...
07 Dec, 2013, 04.41 AM IST
Strides Arcolab plunges over 15% on completion of Agila saleThe pharmaceutical company said it has completed sale of its Agila Specialties Division to Mylan Inc for a total consideration of up to $1....
05 Dec, 2013, 03.15 PM IST
Strides completes $1.75 billion sale of Agila Specialties to MylanStrides Arcolab said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to $1.75 bill...
05 Dec, 2013, 02.22 PM IST
Mylan’s Agila Specialties deal faces riders from US watchdogUS-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...
28 Sep, 2013, 04.00 AM IST
USFDA warning letter to Agila not to affect acquisition: MylanMylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...
17 Sep, 2013, 06.02 PM IST
Strides Arcolab surges over 7 pc as FIPB clears Mylan's FDI proposalSince Mylan's investment proposal is of over Rs 1,200 crore, it will go to the Cabinet Committee on Economic Affairs for final approval.
28 Aug, 2013, 02.18 PM IST
CCI gives green signal to Strides Arcolab-Mylan dealCCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...
25 Jun, 2013, 03.12 PM IST
Strides, Pfenex in pact to develop six biosimilar productsStrides Arcolab and Pfenex Inc have inked a pact to form a JV to develop and manufacture six biosimilar products for the global market.
16 Apr, 2013, 06.24 PM IST
Agila acquisition to help Mylan become global player in injectables: Rajiv MalikThis unique asset will help us significantly expand and diversify our product portfolio and geographic reach, strengthen our presence in th...
08 Mar, 2013, 04.00 AM IST
- Strides Arcolab sells Agila Specialities to Mylan for $1600
Pharmaceutical company Strides Arcolab will sell its specialities division, Agila Specialities to Mylan for $1600 million in cash and a pot...
28 Feb, 2013, 05.57 PM IST
- Pfizer may value Strides unit at Rs 10,000 crore
Pfizer's discussions with Strides Arcolab to acquire the latter's unit, Agila Specialties , is at a fairly advanced stage.
12 Feb, 2013, 09.37 AM IST
Pfizer eyes buyout of Strides Arcolab unit AgilaPfizer is among the companies weighing a purchase of the injectable-medicines unit of Indian drug supplier Strides Arcolab.
25 Jan, 2013, 12.04 PM IST
- Strides Arcolab's Polish sterile facility gets USFDA nod
Strides Arcolab today said its injectables unit Agila Specialties has received US Food and Drug Administration (USFDA) approval for its Pol...
13 Sep, 2012, 05.21 PM IST
Strides Arcolabs unit sale attracts Novartis, Pfizer & Kohlberg Kravis RobertsGlobal drug-makers including Novartis and Pfizer are among ‘serious bidders’ considering bidding for Bangalore-based Strides Arcolabs injec...
17 Aug, 2012, 03.21 PM IST
- Strides Arcolabs' Agila Specialties Pharma Corporation forms JV with Jamp Pharma
Strides Arcolabs' injectable drug division Agila Specialties Pharma Corporation has formed a 70:30 JV with Jamp Pharma to introduce injecta...
11 Jul, 2012, 12.54 PM IST
- Strides rebrands Stride Specialties as Agila Specialties
Drug firm Strides Arcolab today said it has rebranded its specialities division, Strides Specialties as Agila Specialties, and that it will...
25 Nov, 2010, 03.00 PM IST